secobarbital
Check on tripsit
Secobarbital
Check on psychonaut
Secobarbital
Check on isomerdesign
Secobarbital
Check on pubchem
Secobarbital
Check on druglab
Secobarbital
Check on drugmap
Secobarbital
Check on wiki
Data
InChI: InChI=1S/C12H18N2O3/c1-4-6-8(3)12(7-5-2)9(15)13-11(17)14-10(12)16/h5,8H,2,4,6-7H2,1,3H3,(H2,13,14,15,16,17)
Synonyms: 5-ALLYL-5-(1-METHYLBUTYL)BARBITURIC ACID,Quinalbarbitone, Seotal,Meballymalum,Secobarbital, United States Pharmacopeia (USP) Reference Standard,5-Allyl-5-(1-methylbutyl)barbiturate, 5-Allyl-5-(1-methylbutyl)barbiturate,Secobarbital solution, 1 mg/mL in methanol, ampule of 1 mL, certified reference material,Hypotrol, Hypotrol,2,4,6(1H,3H,5H)-Pyrimidinitrione, 5-(1-methylbutyl)-5-(2-propenyl)-,EINECS 200-982-2,Secobarbital,(RS)-Secobarbital,5-(pentan-2-yl)-5-(prop-2-en-1-yl)-1,3-diazinane-2,4,6-trione,Barbituric acid, 5-allyl-5-(1-methylbutyl)-,Secobarbital cii,5-Allyl-5-(1-methylbutyl)malonylurea,Secobarbitale,Quinalbarbital,SECOBARBITAL [USP IMPURITY], Secobarbital solution, (+-)-Secobarbital, Secobarbitone, 5-pentan-2-yl-5-prop-2-enyl-1,3-diazinane-2,4,6-trione,5-allyl-5-(1-methylbutyl)-barbituric acid,Meballymal,HSDB 3182,BRN 0225330, Seconal (TN), Secobarbitalum,Q414788,5-pentan-2-yl-5-prop-2-enyl-1,3-diazinane-2,4,6-trione,Secobarbital solution, 1.0 mg/mL in methanol, analytical standard, for drug analysis, 5-(pentan-2-yl)-5-(prop-2-en-1-yl)-pyrimidine-2,4,6(1H,3H,5H)-trione,(+-)-5-Allyl-5-(1-methylbutyl)-barbituric acid, Quinalbarbitone, Secobarbital suppository dosage form,UNII-1P7H87IN75,BARBITURIC ACID, 5-ALLYL-5-(1-METHYLBUTYL)-, (+-)-,5-allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione, Pramil,Evronal, 5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione,Seconal (TN), 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(1-methylbutyl)-5-(2-propenyl)-, (+-)-(9CI), Quinalbarbital,2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(1-methylbutyl)-5-(2-propenyl)-, (+-)-,Somosal,SECOBARBITAL [USP-RS],GTPL7615,secobarbital,CHEBI:9073, Meballymalum, (+-)-5-Allyl-5-(1-methylbutyl)-barbituric acid,Secobarbital 0.1 mg/ml in Methanol,Hyptran (Salt/Mix), 5-(1-methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione,DTXSID6044145,(+/-)-Secobarbital,5-Allyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione,Secobarbital, analytical standard,Secobarbitalum [INN-Latin],NCGC00247712-01,Secobarbital suppository dosage form [DEA No. 2316],Hyptran,2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(1-methylbutyl)-5-(2-propenyl)-,Trisomnin (Salt/Mix),5-(1-methylbutyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione,Sodium secobarbital,Sodium quinalbarbitone,Secobarbitale [DCIT], Secobarbitale, Secobarbitalum [INN-Latin], Secobarbital [USAN:INN],CHEMBL447,(.+/-.))-Secobarbital,5-(pentan-2-yl)-5-(prop-2-en-1-yl)-pyrimidine-2,4,6(1H,3H,5H)-trione, Hyptran, Seconal,Imesonal (Salt/Mix), Secobarbitale [DCIT], Somosal,D00430,1P7H87IN75,SECOBARBITAL [INN],SCHEMBL80734,Secobarbital sodium free acid,Secobarbital 1.0 mg/ml in Methanol,Secobarbital (USP/INN),76-73-3,5-24-09-00235 (Beilstein Handbook Reference),(+-)-Secobarbital,SECOBARBITAL [VANDF],Immenoctal (Salt/Mix), Evronal,5-(1-Methylbutyl)-5-(2-propen-1-yl)-2,4,6(1H,3H,5H)-pyrimidinetrione,Somatarax,DEA No. 2315,Secobarbitone,Secobarbital suppository dosage form,2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(1-methylbutyl)-5-(2-propen-1-yl)-,(+/-)-Quinalbarbitone,Secobarbitalum,Secobarbital [USP:INN],SECOBARBITAL SODIUM FREE ACID [MI],SECOBARBITAL [WHO-DD],Seconal,5-Pentan-2-yl-5-prop-2-enyl-1,3-diazinane-2,4,6-trione,29071-21-4,Barbosec,seconal,S0223,SECOBARBITAL [HSDB], 5-Allyl-5-(1-methylbutyl)malonylurea,5-ALLYL-5-(1-METHYLBUTYL)BARBITURIC ACID,DB00418,Immenox, 5-allyl-5-(1-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione,SECOBARBITAL [MART.],SCHEMBL11110602,2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(1-methylbutyl)-5-(2-propenyl)-, (+-)- (9CI), Meballymal
Estimated data
Solubility: -2.395 (log(S) in mol/L prediction using SolTranNet)
Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)
Addictivity Prediction: 34.9% (prediction based on www.mdpi.com)
